Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

561 Press Releases
DateTitleCompany
08 May 13 Boehringer Ingelheim joins Structural Genomics Consortium - for further research into uncurable diseases Boehringer Ingelheim
08 May 13 Takeda to Acquire Inviragen, Inc. Takeda
08 May 13 EISAI FILES FOR EARLIER USE OF HALAVEN® (ERIBULIN) FOR THE TREATMENT OF METASTATIC BREAST CANCER Eisai,
Published by
Tonic Life Communications
07 May 13 CPhI China 2013 increases customer content services and expands thanks to a double digit pharma industry growth rate and a burgeoning generics market CPhI,
Published by
De Facto Communications
07 May 13 Recipharm and Synthonics join forces to promote novel drug delivery technology Synthonics,
Published by
Defacto
07 May 13 Aesica partners with the University of Nottingham to develop novel amide chemical synthesis technique Aesica,
Published by
Defacto
07 May 13 CLINTEC INTERNATIONAL AND EDINBURGH NAPIER UNIVERSITY ANNOUNCE LAUNCH OF MASTERS CLINTEC INTERNATIONAL ,
Published by
Defacto
02 May 13 Psychiatric Times Offers CME for Psychiatrists and Other Mental Health Professionals UBM MEDICA,
Published by
PR Newswire
02 May 13 "Tune-In" to Glioblastoma During Brain Cancer Awareness Month in May and Help Novocure Support Those Fighting the Disease EDELMAN WORLDWIDE,
Published by
PR Newswire
02 May 13 Dr. Nilayini, Dr. Shuba Dharmana, Dr.Uday Sidhu,Dr.Tripti Rathore, Dr.Rashmi Lohiya For Skincare Award pharmaleaders,
Published by
Pharmaleaders
01 May 13 Vertex Announces New Data that Showed High Viral Cure Rates with a Total of 12 and 24 Weeks of Telaprevir Combination Treatment Among People with Genotype 1 Hepatitis C Who Have the IL28B CC Genotype Vertex
01 May 13 Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams Lilly
01 May 13 Personalised radiotherapy treatment set to benefit from CERN software Cancer Research UK
30 Apr 13 Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals SELEXIS SA,
Published by
PR Newswire
29 Apr 13 Almac Discovery announces licensing of ALM201 to Shin Poong for development and marketing in South Korea Almac Discovery ,
Published by
Defacto
26 Apr 13 Cherwell Develops Accessory Range for Cleanroom Environmental Monitoring Programmes Cherwell Laboratories
26 Apr 13 CME Medical – Helping to Improve Patient Safety in the Community CME Medical
26 Apr 13 HORIBA to exhibit the Microsemi CRP haematology analyser at Pulse Live 2013 event HORIBA UK Ltd - Medical,
Published by
Alto Marketing
26 Apr 13 Accelerating Novel and Transformative Brain Research: Multi-Investigator Research Initiative (MIRI) Grant Recipients Announced Brain Canada,
Published by
PR Newswire
25 Apr 13 FUJIFILM DIOSYNTH BIOTECHNOLOGIES COMMISSIONS NEW CELL BANKING FACILITY AT BILLINGHAM, UK SITE Fujifilm Diosynth Biotechnologies
24 Apr 13 Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity Lilly,
Published by
PharmiWeb.com
24 Apr 13 Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research Baxter
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
24 Apr 13 BRAVE Awards Now Accepting Nominations Shire
24 Apr 13 GSK delivers Q1 2013 core EPS of 26.9p and dividend of 18p GlaxoSmithKline
24 Apr 13 Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402 Teva
24 Apr 13 Boehringer Ingelheim consistently continues growth phase in financial year 2012 Boehringer Ingelheim
24 Apr 13 Takeda Submits a New Drug Application for the Fixed-Dose Combination of Azilva® and Amlodipine Besylate in Japan Takeda Pharmaceutical Company Limited
24 Apr 13 Novartis discloses compensation for new Chairman and Chairman ad-interim Novartis
Advertising